Tourmaline Bio, Inc. (TRML)

NASDAQ: TRML · Real-Time Price · USD

22.22

+0.74 (3.45%)

At close: Aug 13, 2025, 4:00 PM

21.95

-0.27 (-1.22%)

After-hours: Aug 13, 2025, 7:47 PM EDT

Tourmaline Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 13, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	571	520	532	-	-
Market Cap Growth	24.54%	-2.33%	-	-	-
Enterprise Value	322	238	583	-	-
Last Close Price	22.22	20.28	26.18	-	-
PB Ratio	2.04	1.73	2.60	-	-
P/TBV Ratio	2.04	1.73	2.60	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.07	-0.66
Quick Ratio	-	28.99	40.57	6.06	0.40
Current Ratio	-	30.18	41.76	6.10	0.40
Return on Equity (ROE)	-	-28.99%	-39.66%	-549.77%	-
Return on Assets (ROA)	-	-21.60%	-25.87%	-266.29%	-
Return on Capital (ROIC)	-20.70%	-22.18%	-26.60%	-314.87%	-
Earnings Yield	-15.50%	-14.08%	-7.91%	-	-
FCF Yield	-	-14.86%	-5.29%	-	-
Buyback Yield / Dilution	-53.98%	-433.98%	-441.28%	91.94%	-

Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q